(19)
(11) EP 1 470 115 A1

(12)

(43) Date of publication:
27.10.2004 Bulletin 2004/44

(21) Application number: 03700164.1

(22) Date of filing: 20.01.2003
(51) International Patent Classification (IPC)7C07D 295/26, A61K 31/495, A61P 15/00, A61K 45/06
(86) International application number:
PCT/IB2003/000140
(87) International publication number:
WO 2003/064402 (07.08.2003 Gazette 2003/32)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR
Designated Extension States:
AL LT LV MK RO

(30) Priority: 31.01.2002 GB 0202282

(71) Applicants:
  • Pfizer Limited
    Sandwich,Kent CT13 9NJ (GB)

    GB 
  • PFIZER INC.
    New York, N.Y. 10017 (US)

    AT BE BG CH CY CZ DE DK EE ES FI FR GR HU IE IT LU MC NL PT SE SI SK TR LI 

(72) Inventors:
  • NAYLOR, Alasdair, M.,Pfizer Global Rch. and Dev.
    Sandwich,Kent CT13 9NJ (GB)
  • RUSSELL, Rachel, J.,Pfizer Global Rch. and Dev.
    Sandwich,Kent CT13 9NJ (GB)
  • STREET, Stephen, D. A.,Pfizer Central Research
    Sandwich,Kent CT13 9NJ (GB)
  • TANG, Kim-Wah,Pfizer Global Research and Dev.
    Sandwich,Kent CT13 9NJ (GB)
  • VAN DER GRAAF, P. H.,Pfizer Global Rch. and Dev.
    Sandwich,Kent CT13 9NJ (GB)
  • WAYMAN, Christopher, P.,Pfizer Global Rch. & Dev.
    Sandwich,Kent CT13 9NJ (GB)

(74) Representative: England, Peter Michael 
Pfizer Limited,UK Patent Department,Ramsgate Road
Sandwich,Kent CT13 9NJ
Sandwich,Kent CT13 9NJ (GB)

   


(54) TREATMENT OF MALE SEXUAL DYSFUNCTION